AbbVie is now pushing Skyrizi and Rinvoq to counter the drop in Humira sales and has forecast the two newer drugs to generate ...

Expanded collaboration leverages complementary expertise to unlock next-generation oncology therapeutics Focus on breakthrough ADC payloads and ...

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

The first ALS patient has been enrolled in an NIH-funded expanded access program trial evaluating MN-166 (ibudilast).

FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing ...

U.S. President Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad ...

The global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027).

The wide-ranging executive order signed by Trump aims to reduce healthcare costs. It comes one day after the Trump ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on Tuesday aimed at lowering drug prices and reducing costs for Medicare. The move ...

Avidity's delpacibart etedesiran (del-desiran) was granted orphan drug status in Japan as a treatment for myotonic dystrophy ...

For decades, thousands of women were given a controversial drug during their pregnancies with the hope of preventing miscarriage. The drug, called Diethylstilbestrol – commonly known as DES ...

The Institute of Cancer Research, London (ICR) welcomed the move, which follows decades of research by ICR scientists ...